文献速递抗栓抗凝管理药物不良反应与药物警戒

直接口服抗凝药患者报告结局的系统综述

A systematic review of patient-reported outcomes associated with the use of direct-acting oral anticoagulants.
PubMed 文献 · Br J Clin Pharmacol · 2019-06-26

结果显示DOAC与华法林在健康相关生活质量(HRQoL)和依从性上相似,但患者对DOAC满意度更高、负担更低且获益评分更优,患者倾向选择DOAC;因研究异质性无法得出确定结论。

要点

  • DOAC与华法林在HRQoL评分和依从性上相似。
  • 患者对DOAC的满意度显著更高,负担更低且获益评分更优。
  • 研究异质性较大,无法得出确定性结论。

核心结论

  • 患者似乎更倾向使用DOAC而非华法林,体现在生活质量、满意度和依从性更高,但研究异质性不允许得出确定结论。

研究设计与样本

  • 使用Cochrane协作工具评估随机对照试验偏倚,采用 adapted for cross-sectional studies 的Newcastle-Ottawa量表评估观察性研究。

主要发现

  • 6项研究(1项对照试验、5项观察性研究)评估HRQoL,报告DOAC与华法林患者HRQoL评分相似。
  • DOAC患者HRQoL评分更高,归因于无需像华法林那样密集监测,但无统计学显著性。
  • 多数研究(5项对照试验、9项观察性研究)调查患者报告的满意度,表明对DOAC满意度更高,负担评分显著更低且获益评分显著更高。
  • 患者报告的期望、依从性和遵嘱行为在DOAC与华法林患者间相似。

局限性

  • 分析的研究存在异质性,不允许得出确定结论。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: Patient-reported outcomes (PROs) are a distinctive method of evaluating patient response to health care or treatment. This systematic review aimed to analyse the impact of PROs in patients on direct oral anticoagulant (DOAC) treatment, prescribed for any indication (e.g. venous thromboembolism treatment or atrial fibrillation) using controlled trials (CT) and real-world observational studies (OS). METHODS: A systematic search of articles was conducted according to PRISMA guidelines using databases, with the last update in November 2018. The Cochrane Collaboration tool for assessing bias in randomized CTs and the Newcastle-Ottawa Scale adapted for cross-sectional studies were used. Outcomes evaluated were related to health-related quality of life (HRQoL), satisfaction, adherence and compliance. RESULTS: Twenty-one original studies (6 CT, 15 OS) were included. HRQoL was assessed by 6 (1 CT, 5 OS) studies and reported that HRQoL scores were similar in patients on DOACs and warfarin. Patients prescribed DOACs presented higher HRQoL scores which were attributed to lack of intense monitoring required compared with warfarin but this was not statistically significant. The majority of studies (5 CT, 9 OS) investigated patient-reported satisfaction, indicating greater satisfaction with DOACs with significantly lower burden and increased benefit scores for patients on DOACs. Patient-reported expectations, compliance and adherence were similar for patients on DOACs and warfarin. CONCLUSION: Patients appear to prefer treatment with DOACs vs warfarin. This is shown by the higher quality of life, satisfaction and adherence described in the studies. However, heterogeneity in the analysed studies does not allow firm conclusions.

来源:Br J Clin Pharmacol,查看原文。版权归原作者所有。

引用

  1. Afzal SK, Hasan SS, Babar ZU, et al. A systematic review of patient-reported outcomes associated with the use of direct-acting oral anticoagulants. Br J Clin Pharmacol. 2019. PMID: 31077431. doi:10.1111/bcp.13985

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。